These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 31672653)

  • 1. Decoding regulatory structures and features from epigenomics profiles: A Roadmap-ENCODE Variational Auto-Encoder (RE-VAE) model.
    Hu R; Pei G; Jia P; Zhao Z
    Methods; 2021 May; 189():44-53. PubMed ID: 31672653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenomic analysis reveals DNA motifs regulating histone modifications in human and mouse.
    Ngo V; Chen Z; Zhang K; Whitaker JW; Wang M; Wang W
    Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3668-3677. PubMed ID: 30755522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HebbPlot: an intelligent tool for learning and visualizing chromatin mark signatures.
    Girgis HZ; Velasco A; Reyes ZE
    BMC Bioinformatics; 2018 Sep; 19(1):310. PubMed ID: 30176808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting regulatory variants using a dense epigenomic mapped CNN model elucidated the molecular basis of trait-tissue associations.
    Pei G; Hu R; Dai Y; Manuel AM; Zhao Z; Jia P
    Nucleic Acids Res; 2021 Jan; 49(1):53-66. PubMed ID: 33300042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NUCLIZE for quantifying epigenome: generating histone modification data at single-nucleosome resolution using genuine nucleosome positions.
    Zheng D; Trynda J; Sun Z; Li Z
    BMC Genomics; 2019 Jul; 20(1):541. PubMed ID: 31266464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved detection of epigenomic marks with mixed-effects hidden Markov models.
    Baldoni PL; Rashid NU; Ibrahim JG
    Biometrics; 2019 Dec; 75(4):1401-1413. PubMed ID: 31081192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods for ChIP-seq analysis: A practical workflow and advanced applications.
    Nakato R; Sakata T
    Methods; 2021 Mar; 187():44-53. PubMed ID: 32240773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hyper-activation of transcriptional enhancers in breast cancer.
    Li QL; Wang DY; Ju LG; Yao J; Gao C; Lei PJ; Li LY; Zhao XL; Wu M
    Clin Epigenetics; 2019 Mar; 11(1):48. PubMed ID: 30867030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone ChIP-Seq identifies differential enhancer usage during chondrogenesis as critical for defining cell-type specificity.
    Cheung K; Barter MJ; Falk J; Proctor CJ; Reynard LN; Young DA
    FASEB J; 2020 Apr; 34(4):5317-5331. PubMed ID: 32058623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AIKYATAN: mapping distal regulatory elements using convolutional learning on GPU.
    Fang CH; Theera-Ampornpunt N; Roth MA; Grama A; Chaterji S
    BMC Bioinformatics; 2019 Oct; 20(1):488. PubMed ID: 31590652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated multi-omics analysis of ovarian cancer using variational autoencoders.
    Hira MT; Razzaque MA; Angione C; Scrivens J; Sawan S; Sarker M
    Sci Rep; 2021 Mar; 11(1):6265. PubMed ID: 33737557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. cChIP-seq: a robust small-scale method for investigation of histone modifications.
    Valensisi C; Liao JL; Andrus C; Battle SL; Hawkins RD
    BMC Genomics; 2015 Dec; 16():1083. PubMed ID: 26692029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative epigenomic and high-throughput functional enhancer profiling reveals determinants of enhancer heterogeneity in gastric cancer.
    Sheng T; Ho SWT; Ooi WF; Xu C; Xing M; Padmanabhan N; Huang KK; Ma L; Ray M; Guo YA; Sim NL; Anene-Nzelu CG; Chang MM; Razavi-Mohseni M; Beer MA; Foo RSY; Sundar R; Chan YH; Tan ALK; Ong X; Skanderup AJ; White KP; Jha S; Tan P
    Genome Med; 2021 Oct; 13(1):158. PubMed ID: 34635154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DGW: an exploratory data analysis tool for clustering and visualisation of epigenomic marks.
    Lukauskas S; Visintainer R; Sanguinetti G; Schweikert GB
    BMC Bioinformatics; 2016 Dec; 17(Suppl 16):447. PubMed ID: 28105912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EpiCompare: an online tool to define and explore genomic regions with tissue or cell type-specific epigenomic features.
    He Y; Wang T
    Bioinformatics; 2017 Oct; 33(20):3268-3275. PubMed ID: 28605501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenomic profiling of archived FFPE tissues by enhanced PAT-ChIP (EPAT-ChIP) technology.
    Amatori S; Persico G; Paolicelli C; Hillje R; Sahnane N; Corini F; Furlan D; Luzi L; Minucci S; Giorgio M; Pelicci PG; Fanelli M
    Clin Epigenetics; 2018 Nov; 10(1):143. PubMed ID: 30446010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Semiautomated ChIP-Seq Procedure for Large-scale Epigenetic Studies.
    Cayford J; Herrera-da la Mata S; Schmiedel BJ; Chandra V; Vijayanand P; Seumois G
    J Vis Exp; 2020 Aug; (162):. PubMed ID: 32865528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromatin Immunoprecipitation (ChIP) Protocol for Low-abundance Embryonic Samples.
    Rehimi R; Bartusel M; Solinas F; Altmüller J; Rada-Iglesias A
    J Vis Exp; 2017 Aug; (126):. PubMed ID: 28872116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phylogenetic Modeling of Regulatory Element Turnover Based on Epigenomic Data.
    Dukler N; Huang YF; Siepel A
    Mol Biol Evol; 2020 Jul; 37(7):2137-2152. PubMed ID: 32176292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycomb repressive complex 2 epigenomic signature defines age-associated hypermethylation and gene expression changes.
    Dozmorov MG
    Epigenetics; 2015; 10(6):484-95. PubMed ID: 25880792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.